SNCA and multiple system atrophy: The transgenic mouse model of MSA, based on targeted overexpression of human α-synuclein in oligodendrocytes under the PLP promoter [10] recapitulates many of the features observed in MSA-like oligodendroglial α-synucleinopathy.